BORSA: Stock News & AlertsFree on the App StoreFree on Google PlayGet Get

BORSAStock News & Alerts

Latest News Calendar Reports Stocks Sign in

BORSAStock News & Alerts

Latest News Calendar Reports Stocks Sign in

SPY−0.09%$762.54QQQ0.00%$709.80

TSLA−0.02%$354.64NDAQ+0.88%$94.80AAPL−0.08%$343.19CLF−0.25%$12.12BKR0.00%$55.70NVDA−0.18%$213.74SPCX−0.29%$145.60LRCX0.00%$263.94TOL+0.04%$133.70CBOE−0.06%$314.95SHOP−0.15%$169.26GPRK+0.09%$11.76PSX0.00%$293.17B+0.04%$40.84SMTC−0.53%$136.00LMT+0.05%$552.01EFX+0.05%$161.25XOM−0.01%$178.96CPRT0.00%$27.87BX+0.13%$106.78MRNA+0.23%$218.52DKNG0.00%$18.90GS+0.05%$881.00ROKU0.00%$154.54UNH−0.01%$401.42NFLX−0.09%$70.47MU−0.10%$878.00HPE0.00%$55.13C0.00%$124.27JNJ−0.22%$255.00TSLA−0.02%$354.64NDAQ+0.88%$94.80AAPL−0.08%$343.19CLF−0.25%$12.12BKR0.00%$55.70NVDA−0.18%$213.74SPCX−0.29%$145.60LRCX0.00%$263.94TOL+0.04%$133.70CBOE−0.06%$314.95SHOP−0.15%$169.26GPRK+0.09%$11.76PSX0.00%$293.17B+0.04%$40.84SMTC−0.53%$136.00LMT+0.05%$552.01EFX+0.05%$161.25XOM−0.01%$178.96CPRT0.00%$27.87BX+0.13%$106.78MRNA+0.23%$218.52DKNG0.00%$18.90GS+0.05%$881.00ROKU0.00%$154.54UNH−0.01%$401.42NFLX−0.09%$70.47MU−0.10%$878.00HPE0.00%$55.13C0.00%$124.27JNJ−0.22%$255.00

← Kodiak Sciences (KOD) stock news

Kodiak Sciences (KOD) Stock News: October 2026

$KOD · 2 stories in October 2026

October 2026

newest first · direct subject stories only

Analyst actionOct 12 · 7:46 AM ET

HC Wainwright & Co. lifts Kodiak Sciences price target to $126.00

HC Wainwright & Co. increased its price target for Kodiak Sciences to $126.00 per share.

bullish 70 · impact 30

Kodiak Sciences price target raised by HC Wainwright: a microscope and a glass vial beside a large upward-pointing arrow.

CorporateOct 7 · 7:07 AM ET

Kodiak Sciences to present Phase 3 DAYBREAK, GLOW2, and Phase 1b APEX data at AAO 2026

BORSA News Sentiment is a news-derived editorial measure, separate from price action and not investment advice.

News Calendar Reports Stocks Sign in

Kodiak Sciences (KOD) will present first scientific data from Phase 3 DAYBREAK (wet AMD), Phase 3 GLOW2 (diabetic retinopathy), and Phase 1b APEX (MESI) at AAO 2026. DAYBREAK previously met its primary endpoint.

neutral 50 · impact 30

Kodiak Sciences clinical data presentation: three beams of light converge on a large, stylized human eye.

More Kodiak Sciences coverage$KOD

Latest KOD stock news · September 2026

BORSA News Sentiment is a news-derived editorial measure, separate from price action and not investment advice.